Efficacy and Safety of Once-Daily Atomoxetine Hydrochloride in Adults With ADHD Over an Extended Period of Time (6 Months)

Efficacy and Safety of Once-Daily Atomoxetine Hydrochloride in Adults With ADHD Over an Extended Period of Time (6 Months); With a Brief Evaluation of Executive Cognition

A study to compare the effect of once-daily atomoxetine versus placebo in treating symptoms of ADHD in adults for up to 6 months.

Inclusion Criteria:

• Male and Female patients with ADHD ages 18-54.
• Patient must have ADHD symptoms that cause problem(s) in the home setting.

Exclusion Criteria:

• Have failed to respond to an adequate trial of treatment with an ADHD stimulant medication, bupropion, or other nonstimulant medication.
• Are taking any antipsychotic medication or mood stabilizers within 8 weeks of Visit 1